Liver imaging characteristics in HSCT and non-HSCT cohorts with PLI
| . | HSCT cohort (n = 21) . | Non-HSCT cohort (n = 10) . |
|---|---|---|
| Imaging findings, n (%) | n = 20 with imaging | n = 8 with imaging |
| Normal liver | 11 (55) | 5 (62.5) |
| Biliary duct dilatation | 2 (10) | 1 (12.5) |
| Coarse/cirrhotic liver | 0 | 1 (12.5) |
| Steatosis | 1 (5) | 1∗ (6.3) |
| Periportal edema | 3 (15) | 0 |
| Hepatomegaly | 0 | 0 |
| Splenomegaly | 0 | 0 |
| Nodules/discrete lesions | 1 (5) | 0 |
| Increased stiffness | 2 (10) | 1∗ (6.2) |
| Hepatosplenomegaly, n (%) | 2 (9.5) | 0 |
| Evidence of portal hypertension, n (%) | n=2 | n=1 |
| Ascites | 1 | 1 |
| Splenomegaly | 2 | 0 |
| Thrombocytopenia | 1 | 0 |
| Varices | 0 | 0 |
| Jaundice, n (%) | 4 (19) | 1 (10) |
| Pruritus, n (%) | 2 (9.5) | 0 |
| Encephalopathy, n (%) | 0 | 0 |
| History of gastrointestinal bleeding, n (%) | 1 (4.8) | 1 (10) |
| . | HSCT cohort (n = 21) . | Non-HSCT cohort (n = 10) . |
|---|---|---|
| Imaging findings, n (%) | n = 20 with imaging | n = 8 with imaging |
| Normal liver | 11 (55) | 5 (62.5) |
| Biliary duct dilatation | 2 (10) | 1 (12.5) |
| Coarse/cirrhotic liver | 0 | 1 (12.5) |
| Steatosis | 1 (5) | 1∗ (6.3) |
| Periportal edema | 3 (15) | 0 |
| Hepatomegaly | 0 | 0 |
| Splenomegaly | 0 | 0 |
| Nodules/discrete lesions | 1 (5) | 0 |
| Increased stiffness | 2 (10) | 1∗ (6.2) |
| Hepatosplenomegaly, n (%) | 2 (9.5) | 0 |
| Evidence of portal hypertension, n (%) | n=2 | n=1 |
| Ascites | 1 | 1 |
| Splenomegaly | 2 | 0 |
| Thrombocytopenia | 1 | 0 |
| Varices | 0 | 0 |
| Jaundice, n (%) | 4 (19) | 1 (10) |
| Pruritus, n (%) | 2 (9.5) | 0 |
| Encephalopathy, n (%) | 0 | 0 |
| History of gastrointestinal bleeding, n (%) | 1 (4.8) | 1 (10) |
Same patient had both steatosis and increased stiffness on ultrasound.